A Record Number of Americans Surveyed Say They Are Prepared to Select a Health Plan During Open Enrollment – Yahoo Finance

Sixth-annual UnitedHealthcare Consumer Sentiment Survey provides insights into the health care knowledge, opinions and preferences of Americans during open enrollment
A survey-record 82% of respondents said they are prepared for the fall’s open enrollment season
More than half (53%) of respondents said it is likely they would use virtual care for medical services in the future, while 51% said they would be interested in using a digital fitness app as part of an employer-sponsored well-being program
MINNETONKA, Minn., November 10, 2021–(BUSINESS WIRE)–Most Americans said they are prepared to select a health plan during this year’s open enrollment season, while the COVID-19 pandemic continues to spur interest in virtual care for medical services and digital fitness apps to help people pursue at-home fitness routines.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211110005335/en/
A record number of Americans surveyed said they are prepared for this year’s open enrollment season for health care benefits, while the use of technology to evaluate and access medical services continues to grow amid the COVID-19 pandemic. Source: UnitedHealthcare
These are some of the findings from the sixth-annual UnitedHealthcare Consumer Sentiment Survey, which examines Americans’ opinions about various areas of health care, including open enrollment, technology trends, wellness programs and health plan preferences. Key findings this year include:
Majority of Americans surveyed said they are prepared to select a health plan during the fall’s open enrollment period. A survey-record 82% of insured Americans said they are prepared to select a health plan during open enrollment, with baby boomers (86%) and Gen Xers (85%) the most confident; compared to millennials (79%) and Gen Z (71%).

COVID-19 has influenced the health plan some people intend to choose. Many respondents with a health plan (44%) said COVID-19 influenced, or will influence, their preferred health plan, with 16% interested in an option with lower out-of-pocket costs; 13% looking for more well-being programs or resources; 8% seeking more comprehensive or richer benefits; and 8% wanting a national health plan instead of a regional one. Members of Gen Z were the most likely to be influenced (60%), while baby boomers (31%) were the least.

Many Americans are interested in using virtual resources for medical services, as well as turning to technology to comparison shop for care. More than half (53%) said they are interested in using digital devices, such as smartphones, tablets or laptops, to access care, reflecting the surging interest in telehealth due to the persistent spread of COVID-19. When it comes to comparison shopping, 50% of respondents said they had used the internet or mobile apps to comparison shop for health care during the past year.

Many employees say wellness programs have improved their health. Nearly three-quarters (71%) of survey respondents who are employed and have access to wellness programs said the initiatives have made a positive impact on their health. If offered as part of an employer-sponsored wellness program, more than half (51%) said they would be interested in using a digital fitness resource, such as the Peloton App.
"With access to health benefits and care more important than ever amid COVID-19, this year’s survey indicates growing confidence among some Americans in making more informed benefit decisions during open enrollment, as well as continued interest in using technology to evaluate and access health care," said Rebecca Madsen, chief consumer officer of UnitedHealthcare. "We hope this year’s survey results can contribute to keeping people better informed about their health care benefits and choices."
Open Enrollment Preparedness and Preferences
When it comes to time spent researching health benefits by people with health insurance during open enrollment, 28% said they each year devote less than one hour to the process; nearly one-third (31%) usually spend between one and three hours; and fewer respondents (21%) said they typically allocate more than three hours. Among respondents who actively research health plan options, more than one-quarter (29%) said they expect to spend more time evaluating their benefits this year due to COVID-19.
Many respondents (81%) with health benefits affirmed the importance of specialty benefits, agreeing that having vision and dental coverage options is "important" during open enrollment.
Technology and Transparency Trends
Technology continues to help play an increasingly important role in how people access health information and care. More than half (53%) of survey respondents said they are interested in using virtual care in the future to access medical services, underscoring the greater than 2,800% increase in the use of telehealth amid the COVID-19 pandemic1. Even after the pandemic ends, 20% of respondents said they would prefer a virtual relationship with a primary care physician rather than in person.
With recent efforts to encourage greater transparency related to health care quality and cost information, 50% of respondents said they have used the internet or mobile apps during the last year to comparison shop for medical services. Millennials (64%) and members of Gen Z (54%) were the most likely to use comparison shopping resources, compared to Gen X (50%) and baby boomers (38%). Among all comparison shoppers, 56% said the experience influenced their decision-making process, with an equal number (28%) saying the process prompted them to change either the health care provider or facility they selected for the treatment.
Fitness Trends and Wellness Programs
Since the emergence of COVID-19, 40% of survey respondents said their exercise habits have changed, including 24% who say they exercise less now and 16% indicating they work out more. Most survey respondents who work out said walking (61%) has been their preferred method of exercise, followed by running (27%) and weight training (26%). Nearly one-third (30%) of respondents said they use a digital fitness app as part of their exercise routine, half of whom added this resource for the first time after the emergence of COVID-19. Due also to the pandemic, among people who previously exercised at public gyms, 12% said they have no intention of ever returning.
Among people who said having access to an employer-sponsored well-being program enhanced their health, 35% said the initiative helped them improve their nutrition; 34% said it helped improve their mental health; 34% said it motivated them to pay more attention to their health; and 33% reported improved sleep.
For complete survey results, click here.
About the Survey
The 2021 UnitedHealthcare Consumer Sentiment Survey was conducted Sept. 10-12, 2021, using Engine INSIGHTS CARAVAN® online survey of 1,013 U.S. adults 18 and older. The margin of error was plus or minus 3% at the 95% confidence level.
About UnitedHealthcare
UnitedHealthcare is dedicated to helping people live healthier lives and making the health system work better for everyone by simplifying the health care experience, meeting consumer health and wellness needs, and sustaining trusted relationships with care providers. In the United States, UnitedHealthcare offers the full spectrum of health benefit programs for individuals, employers, and Medicare and Medicaid beneficiaries, and contracts directly with more than 1.3 million physicians and care professionals, and 6,500 hospitals and other care facilities nationwide. The company also provides health benefits and delivers care to people through owned and operated health care facilities in South America. UnitedHealthcare is one of the businesses of UnitedHealth Group (NYSE: UNH), a diversified health care company. For more information, visit UnitedHealthcare at www.uhc.com or follow @UHC on Twitter.
1 UnitedHealthcare internal analysis, 2021.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211110005335/en/
Will Shanley
(714) 204-8005
The Mouvement québécois de la qualité (MQQ) invites you to the Salon sur les meilleures pratiques d'affaires (Salon MPA), Canada's biggest event devoted to continuous improvement and innovation, on November 18. Presented in collaboration with the Government of Quebec, the Salon MPA will bring together thousands of corporate leaders, business experts and quality enthusiasts to discuss key strategies and best practices that have enabled them to achieve sustained growth by improving the productivit
Representing the First Niche Fragrance Brand from India
Tether Operations Limited said that the launch of tether tokens (USDt) on Avalanche would “support the long-term growth and sustainability of the Avalanche network.”
State Street Global Advisors, one of the world's largest investment firms, must gain special approval to hire white men instead of a woman or an ethnic-minority candidate.
For most of the past two years, all the focus has been on the coronavirus, but these biotechs have big plans to develop inoculations against other diseases, too.
Alzheimer's stocks Cassava and Cortexyme diverged Thursday. An analyst says SAVA stock is "back on track," but CRTX stock skidded.
Novavax (NVAX) is getting some momentum for its two-dose COVID-19 vaccine, starting with a series of emergency use fillings globally and the first authorization in Indonesia this month. The company is on track to file with the U.S. Food and Drug Administration (FDA) by the end of the year, and has already called for a meeting with the agency to move forward, according to CEO Stanley Erck. Erck told Yahoo Finance Live on Wednesday that the company expects to hear back from the FDA "very soon" and believes Novavax could receive up to five authorizations in the coming 6-8 weeks globally. But a majority of its distribution of actual doses is likely to start at the beginning of 2022.
Buying low and selling high is old advice, but it has staying power because it works. It’s the common sense way to see gains in any commercial endeavor, and that includes stock investing. There is no ‘trick’ for market investors to find stocks that are priced low – other than making sure that they remain fundamentally sound. This requires some background investigation on each investment, but the rewards can be substantial. One key caution for investors to remember – low stock prices can signal a
Some of what you hear on those Medicare Advantage TV ads is true, but the fine print shows that “free” isn't really “free.”
Vermont has seen COVID-19 cases surge to their highest levels in the pandemic. Here's what health officials think is happening.
Kingshuk Das testifies that former CEO was resistant to critiques of company’s devices Elizabeth Holmes with her mother, Noel Holmes, during her trial in San Jose last month. Photograph: Brittany Hosea-Small/Reuters The former lab director of Theranos has testified that Elizabeth Holmes gave “implausible” excuses for apparent failures in the company’s tests and personally pushed back against his concerns about its signature blood testing machines. Kingshuk Das testified on Tuesday in the high-pr
Nearly 90% of U.S. adults 65 and older currently take at least one prescription medication. More than half (54%) of American seniors take four or more. For the millions with a Medicare drug plan, Open Enrollment may be the one chance to review and find the best coverage for the coming year. Some 24 million Americans have a stand-alone Medicare prescription drug (Part D) plan. Depending on where you live there can be between 10 and 30 different plans available. Comparing your 2022 plan options no
Is AbbVie stock a buy as shares retake their key moving averages on strong third-quarter earnings? Is ABBV stock a buy right now?
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Commences Late-Stage Study Of Heart Failure Treatment Merck & Co., Inc. (NYSE: MRK) announced the initiation of VICTOR, a pivotal Phase 3 cardiovascular clinical trial of Verquvo in patients with chronic heart failure and reduced ejection fraction of 40% or less who have not had a recent worsening heart failure event. Gilead's Partner Announces Positive Phase 2b Data For Antibody-Drug Conjugat
This afternoon (Tuesday, Nov 9), the Clinical Trials on Alzheimer's Disease (CTAD) conference will kick off in Boston. Cassava Sciences (SAVA) will be among those making presentations over the next few days with a poster titled, “Interim Results of an Open-label Study of Simufilam in Mild-to-Moderate Alzheimer’s Disease.” B. Riley analyst Mayank Mamtani expects the presentation to include a more rounded update of the topline 12-month cognition efficacy data released toward the end of Q3. Recall,
Global Health Clinics Ltd. (CSE: MJRX) (FRANKFURT: L002) ("Global Health" or the "Company") is pleased to announce a memorandum of understanding with Cultivarium. The partnership will allow Global Health Clinics' Wonder Scientific division to research and develop psilocybin products to become a supplier of clean-start psilocybe genetics for psychedelics research and novel drug development sectors. This Company is focused on developing new products to supply clinical trials, regulated markets and
The average cost of employer health coverage for a family plan passed $22,000 this year, according to a Kaiser Family Foundation survey, rising at a rate that indicates the pandemic had little impact on the total expense.
Pfizer (NYSE: PFE) has won the title of leader when it comes to coronavirus vaccine prevention. Now, Pfizer may be about to claim leadership in another blockbuster area: coronavirus treatment. Data were so strong that an independent monitoring committee recommended Pfizer stop enrolling patients in the trial — and seek regulatory authorization.
The FDA has granted tentative approval of a Morrisville-based drugmaker's treatment for pulmonary arterial hypertension, but a lawsuit is keeping the company from marketing the drug.
The company's revenue was $126.7 million, compared with only $1.4 million year over year, with most of the increase from collaboration revenue from Seres' co-commercialization license agreement with Nestlé Health Science. The improved financial numbers were only part of the story. On Wednesday, Seres said it had established a collaboration with Swiss pharmaceutical company Bacthera to manufacture SER-109, Seres' lead therapy to treat recurrent Clostridioides difficle infection (rCDI).


Book an appointment